The TTrials showed significant increases in bone mineral density and estimated bone strength, particularly in the spine and hip
These features make changes subtle, slow to appear, and harder to measure compared to visible inflammation in soft tissue
Patients with Multiple Endocrine Neoplasia syndrome type 2, a genetic condition associated with increased risk of medullary thyroid carcinoma, should also avoid treatment with this medication
, AMY/CTR- Phase 3 REDEFINE:
BPC-157 8mg total per bottle 100 mcg 80 sprays/bottle 10mL bottle 97.265% purity 97.265% purity (HPLC) Third-party tested Freedom Diagnostics Identity confirmed Certificate of Analysis Tested by Freedom Diagnostics 03/23/2026 Tested by Janoshik 11/10/2025 Key Ingredients A stable pentadecapeptide (15 amino acids) studied in relation to cytoprotective mechanisms, nitric oxide system interactions, growth factor expression, and angiogenic pathways